We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+3.36%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$24.6B
AUM Growth
-$4.32B
(-15%)
Cap. Flow
-$4.58B
Cap. Flow
% of AUM
-18.6%
Top 10 Holdings %
Top 10 Hldgs %
35.76%
Holding
1,158
New
25
Increased
204
Reduced
826
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI South Korea ETF
EWY
|
+$417M |
| 2 |
Tesla
TSLA
|
+$152M |
| 3 |
Broadcom
AVGO
|
+$74.2M |
| 4 |
Qualcomm
QCOM
|
+$39.4M |
| 5 |
Marvell Technology
MRVL
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$341M |
| 3 |
Applied Materials
AMAT
|
+$243M |
| 4 |
Lam Research
LRCX
|
+$194M |
| 5 |
NVIDIA
NVDA
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 48.84% |
| 2 | Financials | 8.23% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Healthcare | 3.78% |
| 5 | Industrials | 3.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
SandRidge Energy
SD
$516M
| $762K | ﹤0.01% |
46,750
+24,539
| +110% | +$398K |
|
827
Ironwood Pharmaceuticals
IRWD
$639M
| $760K | ﹤0.01% |
216,623
+151,782
| +234% | +$622K |
|
|
BCAX
828
Bicara Therapeutics
BCAX
$1.81B
| $756K | ﹤0.01% |
38,003
-21,816
| -36% | -$376K |
|
829
Boston Properties
BXP
$10.8B
| $753K | ﹤0.01% |
14,505
-4,550
| -24% | -$274K |
|
830
Prime Medicine
PRME
$553M
| $750K | ﹤0.01% |
215,582
+27,871
| +15% | +$106K |
|
831
Clorox
CLX
$11.6B
| $750K | ﹤0.01% |
7,237
-2,978
| -29% | -$338K |
|
832
MGM Resorts International
MGM
$11.7B
| $745K | ﹤0.01% |
20,122
-9,338
| -32% | -$333K |
|
833
Solventum
SOLV
$13.5B
| $744K | ﹤0.01% |
11,390
-4,482
| -28% | -$333K |
|
834
TriCo Bancshares
TCBK
$1.9B
| $743K | ﹤0.01% |
15,626
+2,178
| +16% | +$106K |
|
835
Vaalco Energy
EGY
$602M
| $736K | ﹤0.01% |
116,072
+37,650
| +48% | +$190K |
|
836
Beazer Homes USA
BZH
$905M
| $735K | ﹤0.01% |
38,226
-6,514
| -15% | -$150K |
|
837
Horizon Bancorp
HBNC
$1.03B
| $735K | ﹤0.01% |
44,367
+235
| +0.5% | +$4.02K |
|
838
Veeva Systems
VEEV
$29.8B
| $735K | ﹤0.01% |
4,183
-629
| -13% | -$124K |
|
839
Hovnanian Enterprises
HOV
$764M
| $733K | ﹤0.01% |
6,612
-949
| -13% | -$111K |
|
840
Absci
ABSI
$1.4B
| $723K | ﹤0.01% |
240,958
+36,136
| +18% | +$105K |
|
841
Old Second Bancorp
OSBC
$1.21B
| $720K | ﹤0.01% |
35,695
-7,354
| -17% | -$148K |
|
842
Alexandria Real Estate Equities
ARE
$8.69B
| $713K | ﹤0.01% |
15,349
-4,762
| -24% | -$251K |
|
843
Altimmune
ALT
$543M
| $712K | ﹤0.01% |
231,271
+35,505
| +18% | +$151K |
|
844
Byline Bancorp
BY
$1.71B
| $711K | ﹤0.01% |
22,524
-5,900
| -21% | -$185K |
|
845
Capitol Federal Financial
CFFN
$1.07B
| $711K | ﹤0.01% |
99,705
+6,112
| +7% | +$43.5K |
|
846
Emergent Biosolutions
EBS
$394M
| $707K | ﹤0.01% |
85,199
-3,819
| -4% | -$39.6K |
|
847
Domino's
DPZ
$10.7B
| $702K | ﹤0.01% |
1,956
-755
| -28% | -$298K |
|
848
Fox Class A
FOXA
$23.8B
| $702K | ﹤0.01% |
12,012
-5,440
| -31% | -$347K |
|
849
Allogene Therapeutics
ALLO
$642M
| $689K | ﹤0.01% |
+282,346
| New | +$566K |
|
850
XPO
XPO
$25.2B
| $683K | ﹤0.01% |
3,512
-507
| -13% | -$90.9K |
|
Similar funds
CS
AF
SC
RG
JG
Rafferty Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Rafferty Asset Management held 1,158 positions worth $24.6B, down 15% from $28.9B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Rafferty Asset Management withdrew a net $4.58B in Q1 2026, closing 101 positions and reducing 826 holdings. Its most notable exit was AstraZeneca, an estimated $12.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Rafferty Asset Management opened a new position in FTAI Aviation worth $6.39M.
- Rafferty Asset Management's largest Q1 2026 buy was FTAI Aviation: 26,098 shares worth $6.39M.
- Rafferty Asset Management added most to iShares MSCI South Korea ETF in Q1 2026, an estimated $417M increase.
- Rafferty Asset Management's biggest Q1 2026 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $647M.
- Rafferty Asset Management fully exited AstraZeneca in Q1 2026, selling an estimated $12.3M.
- Rafferty Asset Management's ten largest holdings make up 36% of its $24.6B portfolio in Q1 2026.
- Rafferty Asset Management opened 25 new positions and closed 101 in Q1 2026.
- Rafferty Asset Management's portfolio value fell 15% quarter-over-quarter to $24.6B.
Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.